Becton, Dickinson and Company (NYSE:BDX) Receives $280.14 Average PT from Analysts

Becton, Dickinson and Company (NYSE:BDX) has been given a consensus recommendation of “Moderate Buy” by the seven analysts that are presently covering the company, Marketbeat Ratings reports. One equities research analyst has rated the stock with a hold rating and six have given a buy rating to the company. The average 12 month price objective among analysts that have issued ratings on the stock in the last year is $280.14.

A number of brokerages recently weighed in on BDX. Barclays raised their price target on shares of Becton, Dickinson and Company from $305.00 to $312.00 and gave the company an “overweight” rating in a report on Monday, May 6th. Evercore ISI lowered their target price on shares of Becton, Dickinson and Company from $290.00 to $285.00 and set an “outperform” rating for the company in a report on Tuesday, July 2nd. Citigroup lowered their target price on shares of Becton, Dickinson and Company from $260.00 to $255.00 and set a “neutral” rating for the company in a report on Wednesday, July 10th. The Goldman Sachs Group began coverage on shares of Becton, Dickinson and Company in a report on Thursday, May 30th. They set a “buy” rating and a $274.00 target price for the company. Finally, StockNews.com raised shares of Becton, Dickinson and Company from a “hold” rating to a “buy” rating in a report on Monday, July 15th.

Insider Transactions at Becton, Dickinson and Company

In other news, EVP Michael David Garrison sold 1,715 shares of Becton, Dickinson and Company stock in a transaction on Tuesday, April 30th. The shares were sold at an average price of $232.81, for a total transaction of $399,269.15. Following the transaction, the executive vice president now directly owns 5,381 shares of the company’s stock, valued at $1,252,750.61. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. In related news, EVP Roland Goette sold 3,300 shares of the business’s stock in a transaction on Wednesday, May 15th. The shares were sold at an average price of $236.73, for a total value of $781,209.00. Following the sale, the executive vice president now directly owns 11,308 shares of the company’s stock, valued at approximately $2,676,942.84. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, EVP Michael David Garrison sold 1,715 shares of the business’s stock in a transaction on Tuesday, April 30th. The shares were sold at an average price of $232.81, for a total transaction of $399,269.15. Following the completion of the sale, the executive vice president now directly owns 5,381 shares in the company, valued at $1,252,750.61. The disclosure for this sale can be found here. Insiders have sold a total of 8,615 shares of company stock valued at $2,033,381 over the last three months. 0.31% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On Becton, Dickinson and Company

Institutional investors have recently added to or reduced their stakes in the stock. Livelsberger Financial Advisory bought a new stake in Becton, Dickinson and Company in the 4th quarter valued at $27,000. OLD Point Trust & Financial Services N A bought a new stake in Becton, Dickinson and Company during the 4th quarter worth about $29,000. DiNuzzo Private Wealth Inc. bought a new stake in Becton, Dickinson and Company during the 4th quarter worth about $30,000. Scarborough Advisors LLC bought a new stake in Becton, Dickinson and Company during the 4th quarter worth about $32,000. Finally, Accordant Advisory Group Inc bought a new stake in Becton, Dickinson and Company during the 1st quarter worth about $35,000. 86.97% of the stock is owned by institutional investors.

Becton, Dickinson and Company Stock Performance

Shares of Becton, Dickinson and Company stock opened at $234.33 on Wednesday. The company has a debt-to-equity ratio of 0.62, a current ratio of 1.41 and a quick ratio of 0.97. The firm has a market cap of $67.72 billion, a P/E ratio of 51.61, a P/E/G ratio of 2.02 and a beta of 0.42. The firm has a 50 day simple moving average of $232.29 and a 200 day simple moving average of $236.26. Becton, Dickinson and Company has a fifty-two week low of $218.75 and a fifty-two week high of $287.32.

Becton, Dickinson and Company (NYSE:BDX) last issued its quarterly earnings results on Thursday, May 2nd. The medical instruments supplier reported $3.17 earnings per share for the quarter, beating analysts’ consensus estimates of $2.97 by $0.20. The business had revenue of $5.05 billion during the quarter, compared to analyst estimates of $5.04 billion. Becton, Dickinson and Company had a net margin of 6.76% and a return on equity of 13.90%. Becton, Dickinson and Company’s revenue for the quarter was up 4.6% compared to the same quarter last year. During the same quarter last year, the business posted $2.86 earnings per share. Sell-side analysts predict that Becton, Dickinson and Company will post 13.04 earnings per share for the current fiscal year.

Becton, Dickinson and Company Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Monday, September 30th. Stockholders of record on Monday, September 9th will be given a dividend of $0.95 per share. This represents a $3.80 dividend on an annualized basis and a dividend yield of 1.62%. Becton, Dickinson and Company’s dividend payout ratio is 83.70%.

Becton, Dickinson and Company Company Profile

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company operates in three segments: BD Medical, BD Life Sciences, and BD Interventional.